212 related articles for article (PubMed ID: 23349302)
1. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.
Maffei R; Bulgarelli J; Fiorcari S; Bertoncelli L; Martinelli S; Guarnotta C; Castelli I; Deaglio S; Debbia G; De Biasi S; Bonacorsi G; Zucchini P; Narni F; Tripodo C; Luppi M; Cossarizza A; Marasca R
Haematologica; 2013 Jul; 98(7):1115-23. PubMed ID: 23349302
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.
Fiorcari S; Martinelli S; Bulgarelli J; Audrito V; Zucchini P; Colaci E; Potenza L; Narni F; Luppi M; Deaglio S; Marasca R; Maffei R
Haematologica; 2015 Feb; 100(2):253-62. PubMed ID: 25398834
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
Kowalska W
Folia Histochem Cytobiol; 2020; 58(1):17-24. PubMed ID: 32176313
[TBL] [Abstract][Full Text] [Related]
4. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of Fcγ-receptors and Toll like receptor CD180 on monocytes from patients with chronic lymphocytic leukaemia.
Tsertsvadze TSh; Mitskevich NG; Ghirdaladze DM; Porakishvili NZ
Georgian Med News; 2015 Feb; (239):35-8. PubMed ID: 25802446
[TBL] [Abstract][Full Text] [Related]
6. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
[TBL] [Abstract][Full Text] [Related]
7. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.
Giannoni P; Pietra G; Travaini G; Quarto R; Shyti G; Benelli R; Ottaggio L; Mingari MC; Zupo S; Cutrona G; Pierri I; Balleari E; Pattarozzi A; Calvaruso M; Tripodo C; Ferrarini M; de Totero D
Haematologica; 2014 Jun; 99(6):1078-87. PubMed ID: 24561793
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells.
Zheng Z; Venkatapathy S; Rao G; Harrington CA
Leukemia; 2002 Dec; 16(12):2429-37. PubMed ID: 12454749
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo.
Seiffert M; Schulz A; Ohl S; Döhner H; Stilgenbauer S; Lichter P
Blood; 2010 Nov; 116(20):4223-30. PubMed ID: 20660791
[TBL] [Abstract][Full Text] [Related]
11. The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.
Qorraj M; Bruns H; Böttcher M; Weigand L; Saul D; Mackensen A; Jitschin R; Mougiakakos D
Leukemia; 2017 Feb; 31(2):470-478. PubMed ID: 27479178
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.
Morande PE; Zanetti SR; Borge M; Nannini P; Jancic C; Bezares RF; Bitsmans A; González M; Rodríguez AL; Galmarini CM; Gamberale R; Giordano M
Invest New Drugs; 2012 Oct; 30(5):1830-40. PubMed ID: 21887502
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.
Schulz A; Toedt G; Zenz T; Stilgenbauer S; Lichter P; Seiffert M
Haematologica; 2011 Mar; 96(3):408-16. PubMed ID: 21134984
[TBL] [Abstract][Full Text] [Related]
14. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells impair the differentiation of CD14(++) CD16(-) CD64(+) classical monocytes into CD14(++) CD16(+) CD64(++) activate monocytes.
Du Rocher B; Mencalha AL; Gomes BE; Abdelhay E
Cytotherapy; 2012 Jan; 14(1):12-25. PubMed ID: 21838603
[TBL] [Abstract][Full Text] [Related]
16. Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.
Marteau JB; Rigaud O; Brugat T; Gault N; Vallat L; Kruhoffer M; Orntoft TF; Nguyen-Khac F; Chevillard S; Merle-Beral H; Delic J
BMC Med Genomics; 2010 Nov; 3():53. PubMed ID: 21062507
[TBL] [Abstract][Full Text] [Related]
17. Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Hanna BS; McClanahan F; Yazdanparast H; Zaborsky N; Kalter V; Rößner PM; Benner A; Dürr C; Egle A; Gribben JG; Lichter P; Seiffert M
Leukemia; 2016 Mar; 30(3):570-9. PubMed ID: 26522085
[TBL] [Abstract][Full Text] [Related]
18. BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia.
Fiorcari S; Maffei R; Vallerini D; Scarfò L; Barozzi P; Maccaferri M; Potenza L; Ghia P; Luppi M; Marasca R
Front Immunol; 2020; 11():2158. PubMed ID: 32983178
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
